169 related articles for article (PubMed ID: 3264643)
1. [Principles of a differentiated immunocorrective therapy].
Perederiĭ VG; Zemskov AM
Vrach Delo; 1988 Aug; (8):71-4. PubMed ID: 3264643
[No Abstract] [Full Text] [Related]
2. [Principles of immunocorrective therapy using the thymus preparation T-activin].
Arion VIa; Ivanushkin EF
Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
[No Abstract] [Full Text] [Related]
3. [Means for enhancing the effectiveness of immunostimulants].
Lazareva DN; Alekhin EK
Farmakol Toksikol; 1987; 50(2):5-12. PubMed ID: 3556213
[No Abstract] [Full Text] [Related]
4. [Immunological status of nephrotuberculosis patients undergoing combined therapy using immunocorrective agents].
Borisov AV; Skosogorenko MG; Petrovskiĭ BV
Probl Tuberk; 1985; (4):44-8. PubMed ID: 3873651
[No Abstract] [Full Text] [Related]
5. [Effectiveness and influence of piperazine adipinate on the immunological indices of furunculosis patients].
Savitskaia LN; Fedorovskaia RF
Vestn Dermatol Venerol; 1985 Sep; (9):9-12. PubMed ID: 3879066
[No Abstract] [Full Text] [Related]
6. In vivo effects of thymic hormones (Imunotim) on immunologic parameters of patients with secondary immunodeficiency diseases.
Crişan M; Stugren C; Gal O; Herold A; Bucurenci N
Roum Arch Microbiol Immunol; 1992; 51(4):213-24. PubMed ID: 1304826
[TBL] [Abstract][Full Text] [Related]
7. [Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug].
Giulling EV; Kravchuk GP; Kazirchuk VE; Maksiuk LV; Zabolotnyĭ DI
Vrach Delo; 1984 Nov; (11):38-42. PubMed ID: 6335615
[No Abstract] [Full Text] [Related]
8. [Methodological problems of screening immunotropic agents].
Uteshev BS
Farmakol Toksikol; 1984; 47(3):5-13. PubMed ID: 6610565
[TBL] [Abstract][Full Text] [Related]
9. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
[No Abstract] [Full Text] [Related]
10. [Current trends in the study of immunosuppressive agents].
Uteshev BS
Farmakol Toksikol; 1981; 44(1):5-12. PubMed ID: 6455303
[TBL] [Abstract][Full Text] [Related]
11. [Basis of immunocorrective therapy among patients with chronic osteomyelitis].
Sachek MG; Novikov DK; Bulavkin VP
Vestn Khir Im I I Grek; 1986 Mar; 136(3):51-3. PubMed ID: 3487867
[TBL] [Abstract][Full Text] [Related]
12. [Infectious endocarditis: immune disorders, differentiated therapy].
Tatarchenko IP; Komarov VT; Savchenko RP
Ter Arkh; 1999; 71(4):44-7. PubMed ID: 10358863
[TBL] [Abstract][Full Text] [Related]
13. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
[No Abstract] [Full Text] [Related]
14. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism].
Mel'nik VP
Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943
[TBL] [Abstract][Full Text] [Related]
15. Prolongation of allograft survival with Ling Zhi-8, a new immunosuppressive drug.
van der Hem LG; van der Vliet JA; Bocken CF; Kino K; Hoitsma AJ; Tax WJ
Transplant Proc; 1994 Apr; 26(2):746. PubMed ID: 8171639
[No Abstract] [Full Text] [Related]
16. [Correction of immunological status of patients with cholelithiasis for the prevention of postoperative complications].
Aleksandrov VN; Ozerov VF; Slobozhankin AD; Tukhvatulina LK; Beliaev LB; Bagnenko SF
Vestn Khir Im I I Grek; 1990 Mar; 144(3):108-11. PubMed ID: 1697996
[TBL] [Abstract][Full Text] [Related]
17. [Combined immunocorrection--a prospective method for treating secondary immunodeficiency].
Perederiĭ VG; Zemskov AM; Provotorov VM; Nikitin AV; Evstratova EF
Vrach Delo; 1989 Jan; (1):96-8. PubMed ID: 2718463
[TBL] [Abstract][Full Text] [Related]
18. [The immunocorrective action of the new synthetic hexapeptide imunofan in pharmacologically induced and ecological immunodeficiency].
Pisarev VM; Baĭmukanova GK; Tutel'ian AV; Pevnitskiĭ LA; Lebedev VV
Vestn Ross Akad Med Nauk; 1995; (12):22-7. PubMed ID: 8664598
[No Abstract] [Full Text] [Related]
19. [The immunostimulating therapy of chronic nonspecific lung diseases (a review)].
Kuznetsov PO
Ter Arkh; 1989; 61(10):125-30. PubMed ID: 2692203
[No Abstract] [Full Text] [Related]
20. [The effect of the yeast polysaccharide rodexman on the function of the immunocompetent cells in patients with pulmonary tuberculosis].
Podgaĭnaia EA
Lik Sprava; 1993 Jul; (8):83-5. PubMed ID: 8079487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
